{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T16:48:33Z","timestamp":1765039713081},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T00:00:00Z","timestamp":1707868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T00:00:00Z","timestamp":1707868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatologie"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s00105-023-05257-9","type":"journal-article","created":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T12:02:16Z","timestamp":1707912136000},"page":"325-339","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Entz\u00fcndliche Dermatosen im Kindes- und Jugendalter","Inflammatory dermatoses in children and adolescents"],"prefix":"10.1007","volume":"75","author":[{"given":"Kira","family":"S\u00fc\u00dfmuth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Magnolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinzenz","family":"Oji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillipp Otto","family":"Koll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Striegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iliana","family":"Tantcheva-Po\u00f3r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,14]]},"reference":[{"key":"5257_CR1","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/MOP.0000000000001137","volume":"34","author":"KK Barry","year":"2022","unstructured":"Barry\u00a0KK, Hawryluk\u00a0EB (2022) Access to pediatric dermatology. Curr Opin Pediatr 34:359\u2013366","journal-title":"Curr Opin Pediatr"},{"key":"5257_CR2","unstructured":"(2023) S3-Leitlinie \u201eAtopische Dermatitis\u201c (AWMF-Registernr. 013-027). https:\/\/register.awmf.org\/de\/leitlinien\/detail\/013-027"},{"key":"5257_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11882-018-0788-4","volume":"18","author":"E Huang","year":"2018","unstructured":"Huang\u00a0E, Ong\u00a0PY (2018) Severe atopic dermatitis in children. Curr Allergy Asthma Rep 18:35","journal-title":"Curr Allergy Asthma Rep"},{"key":"5257_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jaip.2019.06.044","volume":"8","author":"AB Fishbein","year":"2020","unstructured":"Fishbein\u00a0AB, Silverberg\u00a0JI, Wilson\u00a0EJ, Ong\u00a0PY (2020) Update on atopic dermatitis: diagnosis, severity assessment, and treatment selection. J\u00a0Allergy Clin Immunol Prac 8:91\u2013101","journal-title":"J Allergy Clin Immunol Prac"},{"key":"5257_CR5","unstructured":"https:\/\/www.gpau.de\/media\/2015\/pdfs\/GPA-Sonderheft-Neurodermitis-170920_final1_oA.pdf"},{"key":"5257_CR6","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00105-018-4127-4","volume":"69","author":"C Scheerer","year":"2018","unstructured":"Scheerer\u00a0C, Eyerich\u00a0K (2018) Pathogenese des atopischen Ekzems [Pathogenesis of atopic dermatitis. Hautarzt 69:191\u2013196","journal-title":"Hautarzt"},{"key":"5257_CR7","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/pde.14971","volume":"39","author":"HA Ram\u00edrez-Mar\u00edn","year":"2022","unstructured":"Ram\u00edrez-Mar\u00edn\u00a0HA, Silverberg\u00a0JI (2022) Differences between pediatric and adult atopic dermatitis. Pediatr Dermatol 39:345\u2013353","journal-title":"Pediatr Dermatol"},{"key":"5257_CR8","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jaad.2013.10.010","volume":"70","author":"LF Eichenfield","year":"2014","unstructured":"Eichenfield\u00a0LF, Tom\u00a0WL, Chamlin\u00a0SL et\u00a0al (2014) Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J\u00a0Am Acad Dermatol 70:338\u2013351","journal-title":"J Am Acad Dermatol"},{"key":"5257_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000051576","volume":"202","author":"W Uter","year":"2001","unstructured":"Uter\u00a0W, Schwanitz\u00a0HJ, Pfahlberg\u00a0A, Gefeller\u00a0O (2001) Atopic signs and symptoms: assessing the \u2018atopy score\u2019 concept. Dermatology 202:4\u20138","journal-title":"Dermatology"},{"key":"5257_CR10","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.jaad.2018.09.035","volume":"80","author":"YW Yew","year":"2019","unstructured":"Yew\u00a0YW, Thyssen\u00a0JP, Silverberg\u00a0JI (2019) A systematic review and meta-analysis of the regional and age-related differences in atopic dermatitis clinical characteristics. J\u00a0Am Acad Dermatol 80:390\u2013401","journal-title":"J Am Acad Dermatol"},{"key":"5257_CR11","volume-title":"Pityriasis Alba","author":"DN Givler","year":"2023","unstructured":"Givler\u00a0DN, Basit\u00a0H, Givler\u00a0A (2023) Pityriasis Alba. StatPearls"},{"key":"5257_CR12","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0140-6736(20)31286-1","volume":"396","author":"SM Langan","year":"2020","unstructured":"Langan\u00a0SM, Irvine\u00a0AD, Weidinger\u00a0S (2020) Atopic dermatitis. Lancet 396:345\u2013360","journal-title":"Lancet"},{"key":"5257_CR13","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1525-1470.2012.01740.x","volume":"29","author":"V Vachiramon","year":"2012","unstructured":"Vachiramon\u00a0V, Tey\u00a0HL, Thompson\u00a0AE, Yosipovitch\u00a0G (2012) Atopic dermatitis in African American children: addressing unmet needs of a\u00a0common disease. Pediatr Dermatol 29:395\u2013402","journal-title":"Pediatr Dermatol"},{"key":"5257_CR14","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.3390\/jcm12072701","volume":"12","author":"A Chiricozzi","year":"2023","unstructured":"Chiricozzi\u00a0A, Maurelli\u00a0M, Calabrese\u00a0L, Peris\u00a0K, Girolomoni\u00a0G (2023) Overview of atopic dermatitis in different ethnic groups. J\u00a0Clin Med 12:2701","journal-title":"J Clin Med"},{"key":"5257_CR15","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1084\/jem.20172306","volume":"215","author":"JJ Lyons","year":"2018","unstructured":"Lyons\u00a0JJ, Milner\u00a0JD (2018) Primary atopic disorders. J\u00a0Exp Med 215:1009\u20131022","journal-title":"J Exp Med"},{"key":"5257_CR16","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/j.1365-2133.1995.tb16953.x","volume":"132","author":"MS Lewis-Jones","year":"1995","unstructured":"Lewis-Jones\u00a0MS, Finlay\u00a0AY (1995) The children\u2019s dermatology life quality index (CDLQI): initial validation and practical use. Br J Dermatol 132:942\u2013949","journal-title":"Br J Dermatol"},{"key":"5257_CR17","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1046\/j.1365-2133.2003.05157.x","volume":"148","author":"SA Holme","year":"2003","unstructured":"Holme\u00a0SA, Man\u00a0I, Sharpe\u00a0JL, Dykes\u00a0PJ, Lewis-Jones\u00a0MS, Finlay\u00a0AY (2003) The children\u2019s dermatology life quality index: validation of the cartoon version. Br J Dermatol 148:285\u2013290","journal-title":"Br J Dermatol"},{"key":"5257_CR18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.12788\/cutis.0077","volume":"106","author":"A Tracy","year":"2020","unstructured":"Tracy\u00a0A, Bhatti\u00a0S, Eichenfield\u00a0LF (2020) Update on pediatric atopic dermatitis. Cutis 106:143\u2013146","journal-title":"Cutis"},{"key":"5257_CR19","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.anai.2019.04.020","volume":"123","author":"JI Silverberg","year":"2019","unstructured":"Silverberg\u00a0JI (2019) Comorbidities and the impact of atopic dermatitis. Ann Allergy Asthma Immunol 123:144\u2013151","journal-title":"Ann Allergy Asthma Immunol"},{"key":"5257_CR20","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jaci.2018.11.006","volume":"143","author":"AS Paller","year":"2019","unstructured":"Paller\u00a0AS, Spergel\u00a0JM, Mina-Osorio\u00a0P, Irvine\u00a0AD (2019) The atopic march and atopic multimorbidity: many trajectories, many pathways. J\u00a0Allergy Clin Immunol 143:46\u201355","journal-title":"J Allergy Clin Immunol"},{"key":"5257_CR21","first-page":"1528","volume":"6","author":"DA Hill","year":"2018","unstructured":"Hill\u00a0DA, Grundmeier\u00a0RW, Ramos\u00a0M, Spergel\u00a0JM (2018) Eosinophilic esophagitis is a\u00a0late manifestation of the allergic march. J\u00a0Allergy Clin Immunol 6:1528\u20131533","journal-title":"J Allergy Clin Immunol"},{"key":"5257_CR22","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.jaci.2012.10.041","volume":"131","author":"P Yaghmaie","year":"2013","unstructured":"Yaghmaie\u00a0P, Koudelka\u00a0CW, Simpson\u00a0EL (2013) Mental health comorbidity in patients with atopic dermatitis. J\u00a0Allergy Clin Immunol 131:428\u2013433","journal-title":"J Allergy Clin Immunol"},{"key":"5257_CR23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.sleep.2016.06.011","volume":"25","author":"D Camfferman","year":"2016","unstructured":"Camfferman\u00a0D, Short\u00a0MA, Kennedy\u00a0JD, Gold\u00a0M, Kohler\u00a0M, Lushington\u00a0K (2016) Thermoregulation, scratch, itch and sleep deficits in children with eczema. Sleep Med 25:145\u2013150","journal-title":"Sleep Med"},{"key":"5257_CR24","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra2023911","volume":"384","author":"S St\u00e4nder","year":"2021","unstructured":"St\u00e4nder\u00a0S (2021) Atopic dermatitis. N\u00a0Engl J Med 384:1136\u20131143","journal-title":"N Engl J Med"},{"key":"5257_CR25","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1055\/s-0034-1368396","volume":"231","author":"B Sobolewska","year":"2014","unstructured":"Sobolewska\u00a0B, Zierhut\u00a0M (2014) Atopische Keratokonjunktivitis [Atopic keratoconjunctivitis]. Klin Monbl Augenheilkd 231:512\u2013517","journal-title":"Klin Monbl Augenheilkd"},{"key":"5257_CR26","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/jid.2011.435","volume":"132","author":"A De Benedetto","year":"2012","unstructured":"De Benedetto\u00a0A, Kubo\u00a0A, Beck\u00a0LA (2012) Skin barrier disruption: a\u00a0requirement for allergen sensitization? J\u00a0Invest Dermatol 132:949\u2013963","journal-title":"J Invest Dermatol"},{"key":"5257_CR27","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.clindermatol.2017.03.009","volume":"35","author":"CW Rundle","year":"2017","unstructured":"Rundle\u00a0CW, Bergman\u00a0D, Goldenberg\u00a0A, Jacob\u00a0SE (2017) Contact dermatitis considerations in atopic dermatitis. Clin Dermatol 35:367\u2013374","journal-title":"Clin Dermatol"},{"key":"5257_CR28","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1111\/jdv.18345","volume":"36","author":"A Wollenberg","year":"2022","unstructured":"Wollenberg\u00a0A, Kinberger\u00a0M, Arents\u00a0B et\u00a0al (2022) European guideline (EuroGuiDerm) on atopic eczema: part I\u2014systemic therapy. J\u00a0Eur Acad Dermatol Venereol 36:1409\u20131431","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5257_CR29","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1111\/jdv.18429","volume":"36","author":"A Wollenberg","year":"2022","unstructured":"Wollenberg\u00a0A, Kinberger\u00a0M, Arents\u00a0B et al (2022) European guideline (EuroGuiDerm) on atopic eczema\u2014part II: non-systemic treatments and treatment recommendations for special AE patient populations. J\u00a0Eur Acad Dermatol Venereol 36:1904\u20131926","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5257_CR30","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jaad.2020.11.002","volume":"84","author":"H Neale","year":"2021","unstructured":"Neale\u00a0H, Garza-Mayers\u00a0AC, Tam\u00a0I, Yu\u00a0J (2021) Pediatric allergic contact dermatitis. Part I:\u00a0Clinical features and common contact allergens in children. J\u00a0Am Acad Dermatol 84:235\u2013244","journal-title":"J Am Acad Dermatol"},{"key":"5257_CR31","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1097\/MOP.0000000000000919","volume":"32","author":"I Tam","year":"2020","unstructured":"Tam\u00a0I, Yu\u00a0J (2020) Pediatric contact dermatitis: what\u2019s new. Curr Opin Pediatr 32:524\u2013530","journal-title":"Curr Opin Pediatr"},{"key":"5257_CR32","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/DER.0000000000000385","volume":"29","author":"J Yu","year":"2018","unstructured":"Yu\u00a0J, Atwater\u00a0AR, Brod\u00a0B et\u00a0al (2018) Pediatric baseline patch test series: pediatric contact dermatitis workgroup. Dermatitis 29:206\u2013212","journal-title":"Dermatitis"},{"key":"5257_CR33","unstructured":"Vinzenz Oji. DDG\/AWMF Leitlinie (S1) zur Diagnostik und Therapie der Ichthyosen (Aktualisierung)."},{"key":"5257_CR34","doi-asserted-by":"publisher","first-page":"204","DOI":"10.2500\/aap.2019.40.4210","volume":"40","author":"P Comberiati","year":"2019","unstructured":"Comberiati\u00a0P, Pecoraro\u00a0L, Pigozzi\u00a0R, Peroni\u00a0D, Piacentini\u00a0G (2019) Pearls and pitfalls of bathing in atopic dermatitis. Allergy Asthma Proc 40:204\u2013206","journal-title":"Allergy Asthma Proc"},{"key":"5257_CR35","volume-title":"Kinderdermatologie","author":"PH H\u00f6ger","year":"2022","unstructured":"H\u00f6ger\u00a0PH (2022) Kinderdermatologie, 4.\u00a0Aufl. Thieme","edition":"4"},{"key":"5257_CR36","first-page":"38","volume":"3","author":"I Neust\u00e4dter","year":"2021","unstructured":"Neust\u00e4dter\u00a0I, Walter\u00a0C, Ott\u00a0H, Scheewe\u00a0S, Spindler\u00a0T, Gerstlauer\u00a0M, Kerzel\u00a0S, Nemat\u00a0K, Gappa\u00a0M, Schmidt\u00a0S, N\u00fc\u00dflein\u00a0T, Gellhaus\u00a0I, Straube\u00a0H (2021) Stellungnahme der GPA Atopisches Ekzem: Indikationskriterien f\u00fcr eine systemische Therapie. P\u00e4diatr Allergol Klin Prax 3:38\u201340","journal-title":"P\u00e4diatr Allergol Klin Prax"},{"key":"5257_CR37","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1111\/pde.14820","volume":"38","author":"JJ Parker","year":"2021","unstructured":"Parker\u00a0JJ, Sugarman\u00a0JL, Silverberg\u00a0NB et al (2021) Psoriasiform dermatitis during dupilumab treatment for moderate-to-severe atopic dermatitis in children. Pediatr Dermatol 38:1500\u20131505","journal-title":"Pediatr Dermatol"},{"key":"5257_CR38","doi-asserted-by":"publisher","first-page":"932766","DOI":"10.3389\/fmed.2022.932766","volume":"9","author":"K Ali","year":"2022","unstructured":"Ali\u00a0K, Wu\u00a0L, Qiu\u00a0Y, Li\u00a0M (2022) Case report: Clinical and histopathological characteristics of psoriasiform erythema and de novo IL-17A cytokines expression on lesioned skin in atopic dermatitis children treated with dupilumab. Front Med 9:932766","journal-title":"Front Med"},{"key":"5257_CR39","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.jaad.2021.06.017","volume":"86","author":"S Narla","year":"2022","unstructured":"Narla\u00a0S, Silverberg\u00a0JI, Simpson\u00a0EL (2022) Management of inadequate response and adverse effects to dupilumab in atopic dermatitis. J\u00a0Am Acad Dermatol 86:628\u2013636","journal-title":"J Am Acad Dermatol"},{"key":"5257_CR40","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.jaci.2018.03.021","volume":"143","author":"K Malik","year":"2019","unstructured":"Malik\u00a0K, He\u00a0H, Huynh\u00a0TN et\u00a0al (2019) Ichthyosis molecular fingerprinting shows profound TH17 skewing and a\u00a0unique barrier genomic signature. J\u00a0Allergy Clin Immunol 143:604\u2013618","journal-title":"J Allergy Clin Immunol"},{"key":"5257_CR41","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/pde.14590","volume":"38","author":"F Cicek","year":"2021","unstructured":"Cicek\u00a0F, Cekic\u00a0S, Kilic\u00a0SS (2021) Infliximab therapy in an infant with Netherton syndrome. Pediatr Dermatol 38:714\u2013716","journal-title":"Pediatr Dermatol"},{"key":"5257_CR42","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/bjd.18892","volume":"183","author":"S Volc","year":"2020","unstructured":"Volc\u00a0S, Maier\u00a0L, Gritsch\u00a0A, Aichelburg\u00a0MC, Volc-Platzer\u00a0B (2020) Successful treatment of Netherton syndrome with ustekinumab in a\u00a015-year-old girl. Br J Dermatol 183:165\u2013167","journal-title":"Br J Dermatol"},{"key":"5257_CR43","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1001\/jamadermatol.2020.1019","volume":"156","author":"I Luchsinger","year":"2020","unstructured":"Luchsinger\u00a0I, Kn\u00f6pfel\u00a0N, Theiler\u00a0M (2020) Secukinumab therapy for Netherton syndrome. JAMA Dermatol 156:907\u2013911","journal-title":"JAMA Dermatol"},{"key":"5257_CR44","doi-asserted-by":"publisher","first-page":"e152","DOI":"10.1111\/jdv.16883","volume":"35","author":"K S\u00fc\u00dfmuth","year":"2021","unstructured":"S\u00fc\u00dfmuth\u00a0K, Traupe\u00a0H, Loser\u00a0K, St\u00e4nder\u00a0S, Kessel\u00a0C, Wittkowski\u00a0H, Oji\u00a0V (2021) Response to dupilumab in two children with Netherton syndrome: Improvement of pruritus and scaling. J\u00a0Eur Acad Dermatol Venereol 35:e152\u2013e155","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5257_CR45","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000381913","volume":"231","author":"M Augustin","year":"2015","unstructured":"Augustin\u00a0M, Radtke\u00a0MA, Glaeske\u00a0G et\u00a0al (2015) Epidemiology and comorbidity in children with psoriasis and atopic eczema. Dermatology 231:35\u201340","journal-title":"Dermatology"},{"key":"5257_CR46","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/pde.13382","volume":"35","author":"LF Eichenfield","year":"2018","unstructured":"Eichenfield\u00a0LF, Paller\u00a0AS, Tom\u00a0WL, Sugarman\u00a0J, Hebert\u00a0AA, Friedlander\u00a0SF, Siegfried\u00a0E, Silverberg\u00a0N, Cordoro\u00a0KM (2018) Pediatric psoriasis: evolving perspectives. Pediatr Dermatol 35:170\u2013181","journal-title":"Pediatr Dermatol"},{"key":"5257_CR47","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/j.1440-0960.2012.00878.x","volume":"53","author":"S Kapila","year":"2012","unstructured":"Kapila\u00a0S, Hong\u00a0E, Fischer\u00a0G (2012) A comparative study of childhood psoriasis and atopic dermatitis and greater understanding of the overlapping condition, psoriasis-dermatitis. Australas J Dermatol 53:98\u2013105","journal-title":"Australas J Dermatol"},{"key":"5257_CR48","unstructured":"AWMF-S2k-Leitlinie (013-094). Therapie der Psoriasis bei Kindern und Jugendlichen."},{"key":"5257_CR49","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1007\/s13555-022-00761-7","volume":"12","author":"M Sticherling","year":"2022","unstructured":"Sticherling\u00a0M, McPherson\u00a0T, de Lucas Laguna\u00a0R et al (2022) Patient characteristics and treatment patterns in European pediatric patients with psoriasis: a\u00a0real-world, cross-sectional study. Dermatol Ther 12:1793\u20131808","journal-title":"Dermatol Ther"},{"key":"5257_CR50","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1007\/s00112-023-01764-0","volume":"171","author":"H Hamm","year":"2023","unstructured":"Hamm\u00a0H, H\u00f6ger\u00a0PH (2023) Psoriasis im Kindes- und Jugendalter: Kurzes Update und leitliniengerechte Therapie [Psoriasis in children and adolescents]. Monatsschr Kinderheilkd 171:420\u2013429","journal-title":"Monatsschr Kinderheilkd"},{"key":"5257_CR51","first-page":"1","volume":"25","author":"NW Kittler","year":"2020","unstructured":"Kittler\u00a0NW, Cordoro\u00a0KM (2020) Pediatric psoriasis comorbidity screening. Skin Therapy Lett 25:1\u20136","journal-title":"Skin Therapy Lett"},{"key":"5257_CR52","doi-asserted-by":"publisher","first-page":"203","DOI":"10.5021\/ad.2021.33.3.203","volume":"33","author":"SI Cho","year":"2021","unstructured":"Cho\u00a0SI, Kim\u00a0YE, Jo\u00a0SJ (2021) Association of metabolic comorbidities with pediatric psoriasis: a\u00a0systematic review and meta-analysis. Ann Dermatol 33:203\u2013213","journal-title":"Ann Dermatol"},{"issue":"3","key":"5257_CR53","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1001\/jamadermatol.2017.5417","volume":"154","author":"MM Tollefson","year":"2018","unstructured":"Tollefson\u00a0MM et\u00a0al (2018) Association of psoriasis with comorbidity development in children with psoriasis. JAMA Dermatol 154(3):286\u2013292","journal-title":"JAMA Dermatol"},{"issue":"7","key":"5257_CR54","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1001\/jamadermatol.2017.0499","volume":"153","author":"E Osier","year":"2017","unstructured":"Osier\u00a0E, Wang\u00a0AS, Tollefson\u00a0MM et\u00a0al (2017) Pediatric psoriasis comorbidity screening guidelines. JAMA Dermatol 153(7):698\u2013704","journal-title":"JAMA Dermatol"},{"key":"5257_CR55","first-page":"1991","volume":"25","author":"RE Petty","year":"1998","unstructured":"Petty\u00a0RE, Southwood\u00a0TR, Baum\u00a0J et\u00a0al (1998) Revision of the proposed classification criteria for juvenile idiopathic arthritis. J\u00a0Rheumatol 25:1991\u20131994","journal-title":"J Rheumatol"},{"key":"5257_CR56","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor\u00a0W, Gladman\u00a0D, Helliwell\u00a0P, Marchesoni\u00a0A, Mease\u00a0P, Mielants\u00a0H (2006) Classification criteria for psoriatic arthritis: development of new criteria from a\u00a0large international study. Arthritis Rheum 54:2665\u20132673","journal-title":"Arthritis Rheum"},{"key":"5257_CR57","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/1346-8138.16551","volume":"50","author":"C Miao","year":"2023","unstructured":"Miao\u00a0C, Chen\u00a0Y, Wang\u00a0Z, Xiang\u00a0X, Liu\u00a0Y, Xu\u00a0Z (2023) Real-world data on the use of secukinumab and acitretin in pediatric generalized pustular psoriasis. J\u00a0Dermatol 50:258\u2013261","journal-title":"J Dermatol"},{"key":"5257_CR58","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12969-019-0338-1","volume":"17","author":"T Hospach","year":"2019","unstructured":"Hospach\u00a0T, Glowatzki\u00a0F, Blankenburg\u00a0F, Conzelmann\u00a0D, Stirnkorb\u00a0C, M\u00fcllersch\u00f6n\u00a0CS, von den Driesch\u00a0P, K\u00f6hler\u00a0LM, Rohlfs\u00a0M, Klein\u00a0C, Hauck\u00a0F (2019) Scoping review of biological treatment of deficiency of interleukin-36 receptor antagonist (DITRA) in children and adolescents. Pediatr Rheumatol Online\u00a0J 17:37","journal-title":"Pediatr Rheumatol Online J"}],"container-title":["Die Dermatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-023-05257-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-023-05257-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-023-05257-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T12:04:34Z","timestamp":1711454674000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-023-05257-9"}},"subtitle":["Diagnostische und therapeutische Besonderheiten anhand der atopischen Dermatitis und der Psoriasis","Diagnosis and treatment of atopic dermatitis and psoriasis"],"short-title":[],"issued":{"date-parts":[[2024,2,14]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["5257"],"URL":"https:\/\/doi.org\/10.1007\/s00105-023-05257-9","relation":{},"ISSN":["2731-7005","2731-7013"],"issn-type":[{"value":"2731-7005","type":"print"},{"value":"2731-7013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,14]]},"assertion":[{"value":"23 October 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>K.\u00a0S\u00fc\u00dfmuth<\/b>: A.\u00a0Finanzielle Interessen: Ich habe eine F\u00f6rderung durch das Programm \u201eInnovative Medizinische Forschung\u201c (IMF) und durch das Clinician Scientist Programm der DDG und ADF erhalten. \u2013\u00a0Ich war Referentin bei der Julius Zorn GmbH, bei Sanofi und habe Reisekosten vom European Reference Network erhalten.\u00a0\u2013 Nebent\u00e4tigkeit als Medical Writer bei der Nia Health GmbH.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellte Ober\u00e4rztin und Fach\u00e4rztin Dermatologie, Helios Klinikum Berlin-Buch | Mitgliedschaft: ADF, beantragte Mitgliedschaft: AG P\u00e4diatrische Dermatologie. <b>N.\u00a0Magnolo<\/b>: A.\u00a0Finanzielle Interessen: Vortragshonorare f\u00fcr AbbVie, Almirall, Celgene, Eli Lilly, Janssen-Cilag, Novartis, Pfizer, UCB Pharma. \u2013\u00a0Advisory Board\/Berater f\u00fcr AbbVie, Almirall, BMS, Eli Lilly, Leo Pharma, Novartis, UCB Pharma.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellte Dermatologin, Ober\u00e4rztin, Leiterin der Studienambulanz (zentrale Studienkoordination f\u00fcr innovative Dermatologie), Klinik f\u00fcr Hautkrankheiten, Universit\u00e4tshautklinik M\u00fcnster. <b>V.\u00a0Oji<\/b>: A.\u00a0Finanzielle Interessen: V.\u00a0Oji gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Funktionsoberarzt, Klinik f\u00fcr Hautkrankheiten, Universit\u00e4tsklinik M\u00fcnster, Deutschland, und | Praxis am Buddenturm, M\u00fcnster, Deutschland. <b>P.O.\u00a0Koll<\/b>: A.\u00a0Finanzielle Interessen: Reise, Teilnahme, Kongressgeb\u00fchr: ADO 2021, Hannover, Sun Pharma | ADO 2022, Hannover, Sanofi Aventis | AAD 2023 New Orleans, Almirall.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellter Assistenzarzt Dermatologie Uniklinik K\u00f6ln. <b>A.\u00a0Striegel<\/b>: A.\u00a0Finanzielle Interessen: A.\u00a0Striegel gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Niedergelassene \u00c4rztin f\u00fcr Kinder- und Jugendmedizin mit Schwerpunkt p\u00e4diatrische Allergologie und Pneumologie, K\u00f6ln. <b>I.\u00a0Tantcheva-Po\u00f3r<\/b>: A.\u00a0Finanzielle Interessen: I.\u00a0Tantcheva-Po\u00f3r gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Ober\u00e4rztin, Klinik und Poliklinik f\u00fcr Dermatologie und Venerologie, UK K\u00f6ln | Mitgliedschaften: AG \u201eP\u00e4d Dermatologie\u201c im Rahmen der DDG | European Society of Pediatric Dermatology.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf ExternalRef removed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}